Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
10
Métodos estadísticos
7
Ensayos clínicos
6
Investigaciones
6
Metodología
6
Pruebas clínicas
5
Práctica de juicios
5
Blues (Música)
3
Cáncer
3
Ensayos clinicos
3
Administración de justicia
2
Asesinato
2
Biografía
2
Civilización
2
Delitos políticos
2
Derecho
2
Diseño de investigación
2
Estados Unidos
2
Estadística
2
Evolución (Biología)
2
Libretos para óperas
2
Literatura inglesa
2
Medicina
2
Novela alemana
2
Novela estadounidense
2
Novela inglesa
2
Oncología
2
Orientación profesional
2
Política y gobierno
2
Quimioterapia
2
-
343741“…METHODS: PK and PD data from the first-in-human (FIH) clinical trials, including single ascending dose (SAD) and multiple ascending dose (MAD) studies, were used for model development. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343742por Saito, Makoto, Phyo, Aung Pyae, Chu, Cindy, Proux, Stephane, Rijken, Marcus J., Beau, Candy, Win, Htun Htun, Archasuksan, Laypaw, Wiladphaingern, Jacher, Phu, Nguyen H., Hien, Tran T., Day, Nick P., Dondorp, Arjen M., White, Nicholas J., Nosten, François, McGready, Rose“…The patients were managed prospectively by the Shoklo Malaria Research Unit (SMRU) on the Thailand-Myanmar border or were included in hospital-based clinical trials in six Southeast Asian countries. Fixed-effects multivariable penalised logistic regression was used for analysing maternal mortality. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343743“…METHODS: Electronic databases were screened to identify relevant trials. The primary endpoints were pooled objective response rate (ORR) and disease control rate (DCR). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343744“…CONCLUSIONS: In conclusion, four key genes, Tfcp2l1, Kcns3, Olfml2a and Arl4d, significantly associated with the treatment of OGD/R by breviscapine were identified, which provides a theoretical basis for clinical trials. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12920-023-01651-3.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343745por Linkens, Aimée E. M. J. H., Kurstjens, Dennis, Zwietering, N. Anne, Milosevic, Vanja, Hurkens, Kim P. G. M., van Nie, Noémi, van de Loo, Bob P. A., van der Kuy, P. Hugo M., Spaetgens, Bart“…However, recently published large clinical trials (OPERAM and SENATOR) have shown negative results on the use of CDSSs and patient outcomes and strikingly low acceptance of recommendations. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343746“…METHODS: We conducted a longitudinal analysis of PLWH enrolled in two large multicenter clinical trials across China, and outpatients followed at the clinic of Peking Union Medical College Hospital. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343747“…There must be more SRs/MAs and high-quality clinical trials conducted to confirm these findings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40359-023-01313-0.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343748“…All of the random controlled trials(RCTs) were evaluated and collected as eligible studies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343749“…However, further randomized controlled trials are required to verify these results. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13048-023-01277-0.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343750“…Initial studies have shown an acceptable safety profile, but trials assessing the use of dupilumab for a separate indication revealed a higher rate of conjunctivitis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343751por Murthy, Vishnu, Appiah-Kubi, Emmanuel, Nguyen, Kathleen, Thin, Pan, Hotta, Masatoshi, Shen, John, Drakaki, Alexandra, Rettig, Matthew, Gafita, Andrei, Calais, Jeremie, Sonni, Ida“…Further research is necessary to evaluate if PSMA-PET parameters can predict progression-free survival and overall survival and serve as novel endpoints in clinical trials. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41824-023-00178-1.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343752por Record, Christopher J, Skorupinska, Mariola, Laura, Matilde, Rossor, Alexander M, Pareyson, Davide, Pisciotta, Chiara, Feely, Shawna M E, Lloyd, Thomas E, Horvath, Rita, Sadjadi, Reza, Herrmann, David N, Li, Jun, Walk, David, Yum, Sabrina W, Lewis, Richard A, Day, John, Burns, Joshua, Finkel, Richard S, Saporta, Mario A, Ramchandren, Sindhu, Weiss, Michael D, Acsadi, Gyula, Fridman, Vera, Muntoni, Francesco, Poh, Roy, Polke, James M, Zuchner, Stephan, Shy, Michael E, Scherer, Steven S, Reilly, Mary M“…These results have implications for patient selection for upcoming clinical trials.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343753por Chen, Suet Ching, Charmandari, Evangelia, Choi, Jin-Ho, Dou, Xinyu, Gong, Chunxiu, Hamza, Rasha, Harvey, Jamie, Hoffman, Andrew R, Horikawa, Reiko, Johannsson, Gudmundur, Lima Jorge, Alexander Augusto, Miller, Bradley Scott, Roehrich, Sebastian, Savendahl, Lars S, Tserotopolou, Xanthippi, Wajnrajch, Michael Paul, Faisal Ahmed, S“…Some other items including patient involvement in clinical trials, HbA1c in long-acting rhGH therapy and adherence did not meet the MDS criteria but were considered to be important enough to be included and some of the items were merged into one item. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343754“…However, it is important to note that further randomized controlled trials are necessary to validate and authenticate these findings. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343755por Takeuchi, Tsutomu, Nishikawa, Kiyohiro, Yamada, Fumika, Morita, Akimichi, Ohtsuki, Mamitaro, Suzuki, Yasuo, Watanabe, Mamoru, Yamanaka, Hisashi, Hibi, Toshifumi“…INTRODUCTION: Biosimilar CT-P13 was approved with limited data from clinical trials compared to the originator infliximab in biologic-naïve patients with rheumatoid arthritis. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343756“…In addition, we explored the correlation between riskScores and clinical trials and immune-related factors (22 immune-infiltrating cells, tumor microenvironment, 13 immune-related pathways and 24 HLA genes). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343757“…While the vaccines were developed and tested through extensive human trials, historically vaccines have been known to evoke mixed sentiments among the generic demographics. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343758por Meca-Lallana, José E., Prieto González, José M., Caminero Rodríguez, Ana B., Olascoaga Urtaza, Javier, Alonso, Ana M., Durán Ferreras, Eduardo, Espinosa, Raúl, Dotor, Julio, Romera, Mercedes, Ares Luque, Adrián, Pérez Ruiz, Domingo, Calles, Carmen, Hernández, Miguel A., Hervás García, Miguel, Mendoza Rodríguez, Amelia, Berdei Montero, Yasmina, Téllez, Nieves, Herrera Varó, Nicolás, Sotoca, Javier, Presas-Rodríguez, Silvia, Querol Gutierrez, Luis A., Hervás Pujol, Mariona, Batlle Nadal, Jordi, Martín Ozaeta, Gisela, Gubieras Lillo, Laura, Martínez Yélamos, Sergio, Ramió-Torrentà, Lluís, Mallada Frechin, Javier, Belenguer Benavides, Antonio, Gascón-Giménez, Francisco, Casanova, Bonaventura, Landete Pascual, Lamberto, Berenguer, Leticia, Navarro, Laura, Gómez Gutierrez, Montserrat, Durán, Carmen, Rodríguez Regal, Ana, Álvarez, Elena, García-Estévez, Daniel A., López Real, Ana M., Llaneza González, Miguel A., Marzo Sola, María E., Sánchez-Menoyo, José L., Oterino, Agustín, Villaverde González, Ramón, Castillo-Triviño, Tamara, Álvarez de Arcaya, Amaya, Llarena, Cristina“…INTRODUCTION: Teriflunomide is a once-daily oral immunomodulator approved for relapsing forms of multiple sclerosis (MS) or relapsing–remitting multiple sclerosis (RRMS; depending on the local label), based on extensive evidence from clinical trials and a real-world setting on efficacy, tolerability and patient-reported benefits. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343759por Xiao, Runsha, Zheng, Fan, Kang, Kuo, Xiao, Lei, Bi, Anyao, Chen, Yiting, Zhou, Qi, Feng, Xueping, Chen, Zhikang, Yin, Hao, Wang, Wei, Chen, Zihua, Cheng, Xiaomiao, Zeng, Wenbin“…Both in vitro cell imaging and in vivo tumor treatment trials proved that HTI was effectively served as a robust scaffold for tumor labeling and CRC cells clearance. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
343760por Roberts, Tamalee, Keddie, Suzanne H., Rattanavong, Sayaphet, Gomez, Santiago Rayment, Bradley, John, Keogh, Ruth H., Bärenbold, Oliver, Falconer, Jane, Mens, Petra F., Hopkins, Heidi, Ashley, Elizabeth A.“…We searched electronic databases including Medline, Embase, Global Health, Scopus, WoS Science Citation Index, Wiley Cochrane Central Register of Controlled Trials, Africa-Wide Information, LILACS and WHO Global Index. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto